Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS
- 1 January 2001
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 112 (1-2) , 139-145
- https://doi.org/10.1016/s0165-5728(00)00355-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Interferon (IFN)-β treatment enhances CD95 and interleukin 10 expression but reduces interferon-γ producing T cells in MS patientsJournal of Neuroimmunology, 1999
- Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosisBrain, 1999
- Acceleration of Experimental Autoimmune Encephalomyelitis in Interleukin-10-Deficient Mice: Roles of Interleukin-10 in Disease Progression and RecoveryCellular Immunology, 1998
- Recombinant Interferon-β blocks proliferation but enhances interleukin-10 secretion by activated human T-cellsJournal of Neuroimmunology, 1996
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Circulating L-selectin in multiple sclerosis patients with active, gadolinium-enhancing brain plaquesJournal of Neuroimmunology, 1996
- MRI-PET Registration with Automated AlgorithmJournal of Computer Assisted Tomography, 1993
- Rapid Automated Algorithm for Aligning and Reslicing PET ImagesJournal of Computer Assisted Tomography, 1992
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983